MedPath

OXYCODONE AND ACETAMINOPHEN

Approved
Approval ID

0ab033e0-51f1-c2e8-e063-6294a90a0ab1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 21, 2023

Manufacturers
FDA

RedPharm Drug, Inc.

DUNS: 828374897

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

OXYCODONE AND ACETAMINOPHEN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67296-0355
Application NumberANDA087463
Product Classification
M
Marketing Category
C73584
G
Generic Name
OXYCODONE AND ACETAMINOPHEN
Product Specifications
Route of AdministrationORAL
Effective DateNovember 21, 2023
FDA Product Classification

INGREDIENTS (8)

OXYCODONE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: C1ENJ2TE6C
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MK
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
ACETAMINOPHENActive
Quantity: 325 mg in 1 1
Code: 362O9ITL9D
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.